Clinical Trials Logo

Cardiac Event clinical trials

View clinical trials related to Cardiac Event.

Filter by:

NCT ID: NCT04231240 Completed - Cardiac Event Clinical Trials

Correlation Between Hemochron and Istat in Cardiac Surgery (CHIC Study)

CHIC
Start date: July 17, 2020
Phase:
Study type: Observational

Cardiac surgery needs the use of cardiopulmonary bypass. During this time, it is necessary to prevent thrombosis with high level of heparin and to control the good efficiency with a point of care test. Investigators want to test if two different devices, Hemochron and Istat, are giving similar results.

NCT ID: NCT04156594 Completed - Clinical trials for Postoperative Complications

Preoperative Self-assessment for Cardio-pulmonary Risk Stratification

PRESELECT
Start date: November 4, 2019
Phase:
Study type: Observational

This prospective study intends to development and validation a patient self-assessment questionnaire. The aim of the self-assessment, by questionnaire, is to estimate the risk of postoperative pulmonary complications (PPC).

NCT ID: NCT04059627 Completed - Cardiac Event Clinical Trials

Feasibility of the "Heart-track" Rehabilitative Device Prototype

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Abstract Title: "Heart-track" cardiac rehabilitation device prototype designed for exercise training post coronary revascularisation: A usability study Background: Percutaneous Coronary Intervention (PCI) is a common surgical procedure for heart attack patients. International guidelines recommend that all patients complete phase two (outpatient) cardiac rehabilitation (CR) after PCI, as it plays a critical role in reducing five-year cardiovascular mortality and the risk of cardiovascular-related hospital admission. Patients in our institution have suboptimal exercise compliance and effectiveness during cardiac rehabilitation. Root cause analysis identified 'lack of commitment', 'lack of care monitoring and continuity' and 'lack of motivation and engagement' to be key contributing factors. Yet, healthcare resource limitations necessitate innovation for care continuity and patient engagement. "Heart-track", a novel, app-based innovation was created. By 'game-ifying' cardiac rehabilitative exercise training program, "Heart-track" guides and tracks cardiac rehabilitation at home at patient's comfort. Purpose: To explore experiences of app usability in terms of content, functionality and design of the prototype "Heart-track" app to improve user experience. Methods: Twelve community-dwelling adults who are also active member of cardiac rehab support group, aged above 50, and undergone coronary revascularisation for acute myocardial infarction at least 1 year before were recruited. Participants were introduced to "Heart-Track" mobile app system and its navigational characteristics with standardised instructions. Each participant then performed a self-directed Cardiac rehabilitation session using the app. Participants rated their experience with the hardware and software components of "Heart Track", and their acceptance of it as a cardiac rehabilitation tool. Descriptive analysis of quantitative responses were analysed using IBM SPSS software version 19.0 (Armonk, NY: IBM Corp).

NCT ID: NCT03916861 Completed - Renal Insufficiency Clinical Trials

BIA Versus Physician Adjustment in Acute Kidney Injury Patients Requiring Renal Replacement Therapy

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

This study was designed to compare the efficacy of BIA and physician adjustment to prevent intradialytic hypotension in patients with acute kidney injury who received renal replacement therapy. The investigators randomized 9 patients with acute kidney injury and volume overloaded who underwent acute hemodialysis for 45 sessions in Vajira hospital between October 2017 and February 2018. In physician adjust-group (control) estimate by physical examination and fluid balance record. Primary outcome was intradialytic hypotensive episode and secondary outcome was hemodialysis-related adverse events and other clinical outcome.

NCT ID: NCT03646760 Completed - Clinical trials for Coronary Artery Disease

The Improving ATTENDance to Cardiac Rehabilitation Trial

iATTEND
Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The benefits of cardiac rehabilitation are well known. However, despite center based cardiac rehabilitation (CBCR) representing guideline-based care for patients with cardiovascular disease, most patients do not complete the maximum number of sessions allowed by third party insurance payers. As such, many patients may not be receiving the full clinical benefit ascribed to CR. This study will assess the efficacy of an innovative approach to CR delivery on attendance by combining both center-based and remote- or home-based CR sessions. The intervention group combines center-based CR and remote-/home-based CR and is tailored to the individual needs of each patient, accomplished with the assistance of an easy-to-access telecommunications methodology (telemedicine)

NCT ID: NCT03407573 Completed - Anemia Clinical Trials

Restrictive vs Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur

RESULT-NOF
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The investigator wishes to see if it is possible to undertake a study comparing blood transfusion at two different levels of anaemia to see which is best for patients. All patients that present to hospital with a broken hip will be able to take part in the study. If they become anaemic during their treatment they will be allocated to either be transfused when their blood count is less that 9 or less than 7. In all patients, we will measure heart damage with a blood test that is very sensitive. The investigator will also collect data on the incidence of heart attacks and other complications.

NCT ID: NCT03319160 Completed - Clinical trials for Sudden Cardiac Death

LifeVest Safety and Efficacy in Real Life Settings in France

WEARIT France
Start date: February 2, 2017
Phase:
Study type: Observational [Patient Registry]

This post-market study is a prospective observational study evaluating the efficacy and safety of the LifeVest in real-life settings.

NCT ID: NCT03032146 Completed - Cardiac Event Clinical Trials

The Effect of a Cardiac Rehabilitation Program on Active Participation in the Community and Exercise Habits

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to examine the contribution of a cardiac rehabilitation program on the active participation in daily life six months after an acute coronary event. 100 patients will be recruited for the study, 3-10 months after a myocardial infarction and hospitalization in the Emek Medical Center in Afula, Israel. 50 patients recruited for the study who had participated in cardiac rehabilitation will be the experimental group. 50 patients who have not participated in rehabilitation- will be the control group. The groups will be matched for diagnosis, sex and age. Sociodemographic data on patients will be taken from the medical records of the cardiology department and the Cardiac Rehabilitation Institute of the Emek Medical Center.. Course of study: Participants will sign an informed consent form and fill out questionnaires that evaluate active participation in the community. In addition, the physical function and muscle strength of the participants will be evaluated with designated tests. The duration of each meeting will be 60 minutes. HYPOTHESES 1. Patients who participate in a cardiac rehabilitation program will exhibit higher indices of participation in the community than patients who do not participate. 2. Patients who participate in a cardiac rehabilitation program will display higher levels of physical activity when compared with patients who do not participate.

NCT ID: NCT02814084 Completed - Cardiac Event Clinical Trials

Prevena Incision Management

Prevena
Start date: September 13, 2016
Phase: N/A
Study type: Interventional

The question this research project wants to explore is whether using the Prevena Incision Management System (Prevena) will improve sternal wound edge oxygenation in patients undergoing Coronary Artery bypass surgery with Bilateral Internal Mammary Artery grafts.

NCT ID: NCT02778646 Completed - Clinical trials for Percutaneous Coronary Intervention

Detection of Familial Hypercholesterolaemia in Cardiovascular Disease Registry

Start date: January 2003
Phase: N/A
Study type: Observational [Patient Registry]

Familial hypercholesterolaemia (FH) is an autosomal dominant somatic mutation commonly located on the LDL-receptor, APOB, and PCKS9 gene. The estimated prevalence of homozygous FH is estimated at 1 in a million, whereas the prevalence of heterozygous FH ranges from 1/500-1/200 (0.2-0.5%) of the general population. The majority of individuals suffering from FH remain undiagnosed and without treatment. Using preexisting clinical guidelines, this study scored patients within national cardiovascular disease (CVD) registries for FH with the aim of evaluating prevalence of FH among individuals suffering from premature cardiac events within the UK. Following scoring of the registry, this study also examined the relationship between cholesterol and survival after a premature event in order to understand the possible ramifications of untreated FH on patient survival.